
#163: CAR-T Cell Therapy for MS: Hype, Hope, or Future Standard? – A Global Research Update with Prof. Barbara Willekens
CAR-T cell therapy is one of the most promising yet complex developments in multiple sclerosis research. In this in-depth interview, Professor Barbara Willekens explains how the therapy works, who might benefit, and what we know so far about its risks and potential. A scientifically grounded look at a treatment that could reshape the future of MS care.









